James Investment Research’s Tivity Health, Inc. Common Stock TVTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-24,302
Closed -$782K 559
2022
Q1
$782K Buy
24,302
+62
+0.3% +$1.68K 0.08% 165
2021
Q4
$641K Hold
24,240
0.06% 190
2021
Q3
$559K Hold
24,240
0.05% 193
2021
Q2
$638K Hold
24,240
0.05% 190
2021
Q1
$541K Hold
24,240
0.05% 199
2020
Q4
$475K Hold
24,240
0.04% 215
2020
Q3
$340K Sell
24,240
-5,200
-18% -$75K 0.03% 229
2020
Q2
$334K Buy
29,440
+6,000
+26% +$54.8K 0.03% 222
2020
Q1
$147K Sell
23,440
-24,365
-51% -$393K 0.02% 250
2019
Q4
$973K Buy
47,805
+15,940
+50% +$298K 0.07% 183
2019
Q3
$530K Buy
31,865
+9,000
+39% +$156K 0.04% 228
2019
Q2
$376K Buy
22,865
+7,630
+50% +$147K 0.03% 258
2019
Q1
$268K Buy
15,235
+8,000
+111% +$170K 0.02% 503
2018
Q4
$180K Sell
7,235
-20,000
-73% -$665K 0.01% 542
2018
Q3
$876K Sell
27,235
-5,150
-16% -$176K 0.04% 481
2018
Q2
$1.14M Buy
32,385
+50
+0.2% +$1.84K 0.04% 465
2018
Q1
$1.28M Sell
32,335
-52,431
-62% -$2.04M 0.05% 454
2017
Q4
$3.1M Buy
84,766
+84,016
+11,202% +$3.19M 0.11% 155
2017
Q3
$31K Sell
750
-25,650
-97% -$994K ﹤0.01% 666
2017
Q2
$1.05M Buy
+26,400
New +$883K 0.03% 411

Other funds holding TVTY

James Investment Research's TVTY Position: Q2 2022 in Review

James Investment Research sold out of Tivity Health, Inc. Common Stock (TVTY) in Q2 2022, closing a stake of 24,302 shares — an estimated $782K sold.

James Investment Research first reported a position in TVTY in Q2 2017 and held it in 20 quarters. The position peaked at $3.1M in Q4 2017. 4 funds tracked by Wall St. Rank hold TVTY as of Q2 2022.

  • James Investment Research reported no remaining Tivity Health, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • James Investment Research sold 24,302 Tivity Health, Inc. Common Stock shares in Q2 2022, an estimated $782K.
  • James Investment Research first reported a position in Tivity Health, Inc. Common Stock in Q2 2017 and held it in 20 quarters.
  • James Investment Research's Tivity Health, Inc. Common Stock position peaked at $3.1M in Q4 2017.
  • 4 funds tracked by Wall St. Rank held Tivity Health, Inc. Common Stock as of Q2 2022.

Based on James Investment Research's 13F filing for Q2 2022, filed 1 Aug 2022.